What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up
Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution
Read More 4 minute read Pharma Industry News Piramal Pharma Solutions launches $90m U.S. expansion to boost sterile injectables and ADC manufacturing Piramal Pharma Solutions invests $90 million to expand sterile injectables and ADC production in the U.S., positioning itself for major growth. byPallavi MadhirajuJune 30, 2025